MedTrace Logo

Diagnostic Performance of Dogs for the Olfactory Detection of COVID-19

NCT05846074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1548

Last updated 2023-05-31

No results posted yet for this study

Summary

Considering the favorable preliminary data of few european diagnostic studies on dog detection, we develop in 2021 a pilot study in response to the plan of CHU Bordeaux and Nouvelle Aquitaine French region for an expanded, reliable and alternative rapid dog olfactory detection of COVID during pandemic period.

Our hypothesis is that validated olfactory detection on sweat or face mask collection by dogs would increase the acceptability and propensity to be tested in different population groups, given the non-invasive nature of sweat and face mask; compared to the unpleasant aspect of nasal swabs for PCR or rapid antigenic tests.

To reach this objective, we recruited a dog team to be trained and assessed (all-volunteers masters and dogs) and we will recruit participants with positive and negative PCR test. The diagnostic performance of canine olfactory detection of COVID-19 on sweat and face collection will be compared to the nasal SARS-Cov-2 PCR test of the participants.

Conditions

Interventions

DIAGNOSTIC_TEST

sweat samples and used face mask will be collected

Collection of sweat samples and used face mask will take approximately 15 minutes before or after collection for the SARS-Cov PCR test

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Thierry PISTONE, Dr · University Hospital Bordeaux, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-27
Primary Completion
2022-05-28
Completion
2022-06-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05846074 on ClinicalTrials.gov